Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Atara Biotherapeutics, Inc. (ATRA) had Weighted-Average Shares Outstanding (Diluted) of 13.56M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$3.45M |
|
$-4.30M |
|
$0.12M |
|
$3.34M |
|
$7.03M |
|
$-3.57M |
|
$-0.70M |
|
$-4.28M |
|
$-4.28M |
|
$-4.30M |
|
$-4.30M |
|
$-4.30M |
|
$-4.30M |
|
$-3.57M |
|
$-3.62M |
|
13.56M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
13.56M |
$-0.32 |
|
$-0.32 |
|
| Balance Sheet Financials | |
$18.43M |
|
$0.15M |
|
$11.73M |
|
$30.17M |
|
$18.06M |
|
-- |
|
$48.74M |
|
$66.80M |
|
$-36.63M |
|
$-36.63M |
|
$-36.63M |
|
7.21M |
|
| Cash Flow Statement Financials | |
$-45.24M |
|
$9.71M |
|
$16.10M |
|
$25.18M |
|
$5.74M |
|
$-19.43M |
|
$8.23M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.02 |
|
-- |
|
-- |
|
-- |
|
-- |
|
96.67% |
|
-103.50% |
|
-103.50% |
|
-- |
|
-123.81% |
|
-124.62% |
|
$-44.85M |
|
-- |
|
-- |
|
-- |
|
0.11 |
|
-- |
|
1.80 |
|
49.86 |
|
11.75% |
|
11.75% |
|
-14.26% |
|
11.75% |
|
$-5.08 |
|
$-3.31 |
|
$-3.34 |
|